Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-26T06:38:19.580Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbapenem-resistant Enterobacteriaceae epidemiology in Veterans’ Affairs medical centers varies by facility characteristics

Published online by Cambridge University Press:  11 December 2020

Marissa S. Wirth Open the ORCID record for Marissa S. Wirth [Opens in a new window] ,
Margaret A. Fitzpatrick ,
Katie J. Suda ,
Geneva M. Wilson ,
Swetha Ramanathan ,
Martin E. Evans ,
Makoto M. Jones ,
Christopher D. Pfeiffer  and
Charlesnika T. Evans
Marissa S. Wirth*
Affiliation:
Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr Veterans’ Affairs (VA) Medical Center, Hines, Illinois
Margaret A. Fitzpatrick
Affiliation:
Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr Veterans’ Affairs (VA) Medical Center, Hines, Illinois Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois
Katie J. Suda
Affiliation:
Center for Health Equity Research and Promotion, VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, Pennsylvania
Geneva M. Wilson
Affiliation:
Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr Veterans’ Affairs (VA) Medical Center, Hines, Illinois
Swetha Ramanathan
Affiliation:
Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr Veterans’ Affairs (VA) Medical Center, Hines, Illinois
Martin E. Evans
Affiliation:
Lexington VA Medical Center, Lexington, Kentucky
Makoto M. Jones
Affiliation:
Salt Lake City VA, Salt Lake City, Utah University of Utah, Salt Lake City, Utah
Christopher D. Pfeiffer
Affiliation:
Portland VA Health Care System, Portland, Oregon Oregon Health & Science University, Portland, Oregon
Charlesnika T. Evans
Affiliation:
Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr Veterans’ Affairs (VA) Medical Center, Hines, Illinois Preventive Medicine and Center for Health Services and Outcomes Research, Northwestern University, Chicago, Illinois
*
Author for correspondence: Marissa S. Wirth, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

This is an epidemiological study of carbapenem-resistant Enterobacteriaceae (CRE) in Veterans’ Affairs medical centers (VAMCs). In 2017, almost 75% of VAMCs had at least 1 CRE case. We observed substantial geographic variability, with more cases in urban, complex facilities. This supports the benefit of tailoring infection control strategies to facility characteristics.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 42 , Issue 7 , July 2021 , pp. 885 - 889
Check for updates
Creative Commons
This work is classified, for copyright purposes, as a work of the U.S. Government and is not subject to copyright protection within the United States.
Copyright
© The Author(s), 2020. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant I. Morbid Mortal Wkly Rept 2013;62:165–170.Google Scholar
Antibiotic resistant threats in the United States, 2019. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Published 2019. Accessed November 17, 2020.Google Scholar
79 FR 4377. 172VA10P2: VHA Corporate Data Warehouse—VA. US Government Information website. https://www.govinfo.gov/app/details/FR-2014-01-27/2014-01497. Updated March 6, 2019. Accessed March 6, 2019.Google Scholar
Kelly, AM, Mathema, B, Larson, EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents 2017;50:127–134.CrossRefGoogle ScholarPubMed
Ray, MJ, Lin, MY, Weinstein, RA, Trick, WE. Spread of carbapenem-resistant Enterobacteriaceae among Illinois healthcare facilities: the role of patient sharing. Clin Infect Dis 2016;63:889–893.CrossRefGoogle ScholarPubMed
Park, SO, Liu, J, Furuya, EY, Larson, EL. Carbapenem-resistant Klebsiella pneumoniae infection in three New York City Hospitals trended downwards from 2006 to 2014. Open Forum Infect Dis 2016;3(4). doi: 10.1093/ofid/ofw222.CrossRefGoogle ScholarPubMed
Schwartz, KL, Morris, SK. Travel and the spread of drug-resistant bacteria. Curr Infect Dis Rept 2018;20(9). doi: 10.1007/s11908-018-0634-9.Google ScholarPubMed
Gupta, V, Ye, G, Olesky, M, Lawrence, K, Murray, J, Yu, K. National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States. Int J Infect Dis 2019;85:203–211.CrossRefGoogle ScholarPubMed
Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099–1106.CrossRefGoogle ScholarPubMed
Xu, Y, Gu, B, Huang, M, et al. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000–2012 in Asia. J Thorac Dis 2015;7:376–385.Google ScholarPubMed